NCT07173790View on ClinicalTrials.gov

Watch and Wait or Worry and Wait in Indolent Lymphoma

Not yet recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

September 10, 2025

Primary Completion Date

September 10, 2027

Study Completion Date

September 10, 2027

Conditions

Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)Marginal Zone Lymphoma(MZL)Follicular Lymphoma, Grade 1Follicular Lymphoma, Grade 2Waldenström Macroglobulinemia (WM)Lymphoplasmacytic Lymphoma

Interventions

OTHER

Patient-Reported Outcomes Survey

Participants will complete validated questionnaires including EORTC QLQ-C30, EQ-5D-5L, and disease-specific modules (QLQ-CLL17, QLQ-NHL). Responses will be used to assess quality of life and psychological distress during watchful waiting.

All Listed Sponsors

lead

Seoul National University Hospital

OTHER

NCT07173790 - Watch and Wait or Worry and Wait in Indolent Lymphoma | Biotech Hunter | Biotech Hunter